AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1827086
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg fosinopril
Trial: 1827086
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg fosinopril
Trial: 1827086
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg fosinopril
Trial: 1827086
Drug: Fosinopril (10-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosinopril (10-80 mg) with or without chlorthalidone
Trial: 6887757
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cotrimoxazole, polymyxin B and nystatin (group A)
Trial: 6887757
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nalidixic acid, polymyxin B, neomycin and nystatin (group B)
Trial: 31974022
Drug: Prompt describing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prompt describing adulterants as pharmacologically-active, potentially-harmful compounds
Trial: 26600270
Drug: IL-2 infusion
RxNorm normalized name: Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor
DrugBank: Tagraxofusp (DB14731)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: IL-2 infusion
Trial: 22136163
Drug: levodopa/carbidopa intestinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levodopa/carbidopa intestinal gel
Trial: 16301268
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of EST and EPWA
Trial: 7852210
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (rHuEPO) for treating maternal pregnancy anemia; specific dosage and duration not mentioned.
Trial: 1006255
Drug: RU 43-715
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RU 43-715 (nonsteroid anti-inflammatory agent)
Trial: 25762461
Drug: Standard cilengitide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cilengitide (2000 mg 2×/wk; n = 88)
Trial: 25762461
Drug: Intensive cilengitide
RxNorm normalized name: Cilengitide
DrugBank: Cilengitide (DB11890)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive cilengitide (2000 mg 5×/wk during wk 1‐6, thereafter 2×/wk; n = 88)
Trial: 23650397
Drug: GSK650394 (small
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK650394 (small molecule inhibitor for SGK1)
Trial: 23650397
Drug: GSK650394 combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK650394 combined with RU486 (GR antagonist)
Trial: 21135196
Drug: MBSR therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MBSR therapy plus traditional therapy
Trial: 17011443
Drug: Whole-pelvis radiotherapy
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-pelvis radiotherapy (WP RT) + neoadjuvant and concurrent hormonal therapy (N&CHT)
Trial: 17011443
Drug: Mini-pelvis radiotherapy
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mini-pelvis radiotherapy (MP RT) + neoadjuvant and concurrent hormonal therapy (N&CHT)
Trial: 17011443
Drug: Prostate-only radiotherapy
RxNorm normalized name: Sus scrofa prostate preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostate-only radiotherapy (PO RT) + neoadjuvant and concurrent hormonal therapy (N&CHT)
Trial: 11766085
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel cleansing plus oral antimicrobial prophylaxis with kanamycin and erythromycin for 2 days prior to surgery (group 2)
Trial: 9806257
Drug: Tibolone treatment
RxNorm normalized name: TIBOLONE
DrugBank: Tibolone (DB09070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone treatment
Trial: 8273859
Drug: Cefazolin 1
RxNorm normalized name: cefazolin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 1 g intravenously every 8 hours for 48 hours (8 doses, n = 425)
Trial: 8273859
Drug: Cefuroxime 1.5
RxNorm normalized name: cefuroxime 1.5 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime 1.5 g 1 hour prior to surgery plus 1.5 g every 12 hours for 3 additional doses (4 doses, n = 277)
Trial: 3446308
Drug: Phenelzine (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenelzine (high dose)
Trial: 2706320
Drug: BY912 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BY912 400 mg theophylline capsules
Trial: 2706320
Drug: Theo-24 capsules
DrugBank: Theophylline (DB00277)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Theo-24 capsules
Trial: 23228670
Drug: Morphine 0.1mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.1mg (Group A)
Trial: 23228670
Drug: Fentanyl 10
RxNorm normalized name: FENTANYL 100MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 10 μg (Group B)
Trial: 23228670
Drug: Fentanyl 10
RxNorm normalized name: FENTANYL 100MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 10 μg + bilateral TAP block (Group C)
Trial: 21310284
Drug: Chlormadinone acetate
RxNorm normalized name: Chlormadinone acetate
DrugBank: Chlormadinone acetate (DB15903)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlormadinone acetate (CMA, 10 mg/day)
Trial: 21310284
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate (CPA, 50 mg/day)
Trial: 12869082
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg twice daily plus 20 mg of omeprazole daily
Trial: 10597744
Drug: Sequential intensification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential intensification program (SEQ‐INT)
Trial: 10597744
Drug: Conventional chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional chemotherapy regimen (CMF)
Trial: 8983396
Drug: Clinoril tablets
DrugBank: Sulindac (DB00605)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clinoril tablets
Trial: 30863028
Drug: CAU (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAU (no active treatment)
Trial: 23593932
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 mg per day maximum)
Trial: 14987306
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray (FPANS) 200 microg once daily plus cetirizine (CTZ) 10 mg
Trial: 14987306
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray (FPANS) 200 microg once daily plus montelukast (MSK) 10 mg
Trial: 14987306
Drug: Cetirizine (CTZ)
DrugBank: Cetirizine (DB00341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetirizine (CTZ) 10 mg plus montelukast (MSK) 10 mg
Trial: 14987306
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (FPANS, FPANS plus CTZ, FPANS plus MSK, CTZ plus MSK)
Trial: 15101888
Drug: Fentanyl 25-microg/h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 25-microg/h patch with local heat
Trial: 15101888
Drug: Fentanyl 25-microg/h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 25-microg/h patch without local heat
Trial: 30888908
Drug: Combined locoregional
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined locoregional and systemic therapy
Trial: 30888908
Drug: Locoregional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Locoregional therapy alone
Trial: 29877727
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for pediatric anxiety disorders
Trial: 26530743
Drug: 48 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 48 Gy in 4 consecutive daily fractions (arm 2)
Trial: 21961181
Drug: Thalidomide induction
RxNorm normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide induction therapy
Trial: 14558437
Drug: Theophyllin 400
RxNorm normalized name: theophylline 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophyllin 400 retard Heumann (formulation A) - 400 mg once daily
Trial: 14558437
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution (formulation B) - 133 mg t.i.d.
Trial: 14558437
Drug: Theophylline sustained
RxNorm normalized name: Theophylline
DrugBank: Theophylline (DB00277)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Theophylline sustained release formulation C - 375 mg once daily
Trial: 9487832
Drug: Braun Oral‐B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun Oral‐B Interclean‐ID2 with Flexi‐Tip gingival massage attachment
Trial: 31902935
Drug: Educational Program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational Program for Promoting Appropriate Self-medication via Pharmacies and Pharmacists
Trial: 31902935
Drug: Medication/health class
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication/health class (control group)
Trial: 15908647
Drug: Doxorubicin-cyclophosphamide (AC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin-cyclophosphamide (AC) neoadjuvant chemotherapy (n = 24)
Trial: 15908647
Drug: Doxorubicin-docetaxel (AD)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxorubicin-docetaxel (AD) neoadjuvant chemotherapy (n = 24)
Trial: 15908647
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of pretreatment biopsy and tumor excised after chemotherapy
Trial: 12935395
Drug: Leflunomide at
RxNorm normalized name: Leflunomide
DrugBank: Leflunomide (DB01097)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Leflunomide at 20 mg once daily
Trial: 12935395
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) at 15 mg once weekly
Trial: 11214769
Drug: Carvedilol 12.5
RxNorm normalized name: carvedilol 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 12.5 mg/day for 2 days and then 25 mg/day for 5 days
Trial: 2680994
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg mesterolone daily
Trial: 2680994
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg mesterolone daily
Trial: 781228
Drug: Fenoprofen (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoprofen (200 to 800 mg every six hours, median daily dose 1.8 gm)
Trial: 28010884
Drug: Lumbar cistern
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lumbar cistern drainage combined with intrathecal injection of antibiotics (LCD-ITI)
Trial: 23665469
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 150mg daily
Trial: 23665469
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 75mg daily
Trial: 19057373
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate 5 mg/kg/d
Trial: 19057373
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate 20 mg/kg/d
Trial: 27596682
Drug: Submerged implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Submerged implants (n=30)
Trial: 25877514
Drug: Social‐cognitive theory‐guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social‐cognitive theory‐guided oral hygiene intervention (three face‐to‐face educational hands‐on sessions facilitated by a dentist)
Trial: 16164475
Drug: Massage treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage treatment and handholding (Control)
Trial: 12098616
Drug: Ketamine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.1 mg/kg followed by 4 microg/kg/min)
Trial: 12004808
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of morphine and ketamine
Trial: 10398973
Drug: LumenHance (manganese
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LumenHance (manganese chloride-based oral contrast agent)
Trial: 1702939
Drug: Enteral nutrition
RxNorm normalized name: ENTERAL NUTRITION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral nutrition administered by needle‐catheter jejunostomy
Trial: 1702939
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition administered by total parenteral nutrition
Trial: 23740226
Drug: Subcutaneous golimumab
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Subcutaneous golimumab 50 mg monthly for 6 months
Trial: 23740226
Drug: Intravenous plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous plus subcutaneous golimumab
Trial: 22852834
Drug: Nurse-administered Tobacco
RxNorm normalized name: Tobacco leaf
DrugBank: Tobacco leaf (DB10710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-administered Tobacco Tactics intervention
Trial: 20823391
Drug: Multifactorial intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multifactorial intervention including pill counting, family support, and educational information.
Trial: 18634504
Drug: YU BHK
RxNorm normalized name: Yu Jin
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YU BHK Rabivak vaccine candidate
Trial: 18634504
Drug: Rabipur (commercially
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabipur (commercially available vaccine)
Trial: 15805799
Drug: Antioxidant therapy
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant therapy (specifics not provided)
Trial: 15805799
Drug: Other combinations
RxNorm normalized name: Iron in other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other combinations of antioxidant therapies
Trial: 12394560
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care for cancer treatment-related fatigue
Trial: 25509922
Drug: Gepatomax Forte
RxNorm normalized name: Erythroped Forte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gepatomax Forte in conjunction with basal therapy for 4 weeks
Trial: 25509922
Drug: Basal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal therapy only for 4 weeks
Trial: 20667604
Drug: Carboplatin chemotherapy
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin chemotherapy (3-4 courses)
Trial: 20667604
Drug: Carboplatin chemotherapy
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin chemotherapy (higher doses)
Trial: 20667604
Drug: Baseline measurement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline measurement (before chemotherapy)
Trial: 11260540
Drug: Cyclosporine (Neoral)
RxNorm normalized name: CYCLOSPORINE (NEORAL) 25MG CAP
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (Neoral) treatment until clearance or for a maximum of 12 weeks, followed by randomization into two groups: Group A (stop abruptly) and Group B (taper dose by 1 mg/kg per day until cessation within 4 weeks)
Trial: 11260540
Drug: Cyclosporine (Neoral)
RxNorm normalized name: CYCLOSPORINE (NEORAL) 25MG CAP
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (Neoral) treatment
Trial: 9652881
Drug: Low-dose nitroglycerin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose nitroglycerin patches (5 mg/24 h each)
Trial: 8093138
Drug: Cranberry beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry beverage (300 mL per day)
Trial: 3147901
Drug: Oxyntomodulin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxyntomodulin infusion
Trial: 24132705
Drug: Compound Amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound Amlodipine Tablets with high-fat breakfast
Trial: 24132705
Drug: Compound Amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound Amlodipine Tablets with overnight fast
Trial: 23531328
Drug: DHA-rich fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-rich fish oil (900 mg DHA plus 180 mg EPA)
Trial: 20193646
Drug: Continuation electroconvulsive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation electroconvulsive therapy (C-ECT) with 10 treatments
Trial: 19013293
Drug: Triiodothyronine (T(3))
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triiodothyronine (T(3)) at doses of 50 to 75 microg/d
Trial: 8921055
Drug: Highly purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly purified human follicle‐stimulating hormone (FSH‐HP), administered s.c. (n = 19)
Trial: 8921055
Drug: Human menopausal
RxNorm normalized name: Human menopausal gonadotropin
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human menopausal gonadotrophin (HMG), administered i.m. (n = 20)
Trial: 8255126
Drug: Dipyrone 1
RxNorm normalized name: dipyrone 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone 1 g
Trial: 30913305
Drug: Standard fractionation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard fractionation radiotherapy concurrent with cisplatin (RTOG-0129)
Trial: 30913305
Drug: Accelerated fractionation
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated fractionation radiotherapy concurrent with cisplatin (RTOG-0522)
Trial: 30217172
Drug: IFN β‐1a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN β‐1a 22 μg
Trial: 30217172
Drug: IFN β‐1a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN β‐1a 44 μg
Trial: 20656351
Drug: Intravitreal injections
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injections for CNV
Trial: 15231557
Drug: Intramuscular haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular haloperidol (10 mg) plus promethazine (25-50 mg mix)
Trial: 11438315
Drug: CEE 0.45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE 0.45 mg/day
Trial: 11438315
Drug: CEE 0.625/MPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE 0.625/MPA 2.5 mg/day
Trial: 11438315
Drug: CEE 0.45/MPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE 0.45/MPA 2.5 mg/day
Trial: 11438315
Drug: CEE 0.45/MPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE 0.45/MPA 1.5 mg/day
Trial: 11438315
Drug: CEE 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE 0.3 mg/day
Trial: 11438315
Drug: CEE 0.3/MPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE 0.3/MPA 1.5 mg/day
Trial: 27833860
Drug: Lignocaine (2%)
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lignocaine (2%) injection with topical adrenaline (1:10,000)
Trial: 15610370
Drug: Ketotifen fumarate
RxNorm normalized name: Ketotifen Fumarate
DrugBank: Ketotifen (DB00920)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketotifen fumarate 0.025% ophthalmic solution (single dose)
Trial: 15610370
Drug: Ketotifen fumarate
RxNorm normalized name: Ketotifen Fumarate
DrugBank: Ketotifen (DB00920)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketotifen fumarate 0.025% ophthalmic solution (multiple doses)
Trial: 15610370
Drug: Ketotifen fumarate
RxNorm normalized name: Ketotifen Fumarate
DrugBank: Ketotifen (DB00920)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketotifen fumarate 0.025% ophthalmic solution (single and multiple doses)
Trial: 15610370
Drug: Vehicle placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle placebo (single dose)
Trial: 15610370
Drug: Vehicle placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle placebo (multiple doses)
Trial: 11581550
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (20 g/d for first 5 days, then 5 g/d)
Trial: 4393372
Drug: Methysergide 3-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methysergide 3-6 mg daily